Ulcerative Colitis Exacerbation after Rituximab Treatment in Posttransplant Lymphoproliferative Disease.

MLA

Klug, Maximiliano, et al. “Ulcerative Colitis Exacerbation after Rituximab Treatment in Posttransplant Lymphoproliferative Disease.” Radiology. Imaging Cancer, vol. 4, no. 4, July 2022, p. e220033. EBSCOhost, https://doi.org/10.1148/rycan.220033.

APA

Klug, M., Apter, S., Eshet, Y., & Marom, E. M. (2022). Ulcerative Colitis Exacerbation after Rituximab Treatment in Posttransplant Lymphoproliferative Disease. Radiology. Imaging Cancer, 4(4), e220033. https://doi.org/10.1148/rycan.220033

Chicago

Klug, Maximiliano, Sara Apter, Yael Eshet, and Edith Michelle Marom. 2022. “Ulcerative Colitis Exacerbation after Rituximab Treatment in Posttransplant Lymphoproliferative Disease.” Radiology. Imaging Cancer 4 (4): e220033. doi:10.1148/rycan.220033.